MPM BIOVENTURES V L.P. 13D and 13G filings for Rhythm Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2020-06-26 3:27 pm Sale |
2020-06-24 | 13D | Rhythm Pharmaceuticals, Inc. RYTM |
MPM BIOVENTURES V L.P. | 1,934,558 4.400% |
-468,939 (-19.51%) |
Filing |